We propose that PTEN mutation or inactivation is one means by which tumor cells become resistant to ER stress-induced apoptosis, resulting in increased ATF6 and enhanced Entpd5/IGF1R expression, promoting protein glycosylation and folding. The gene discussed is PTEN; the disease is neoplasm.